Specific activation of AP-1 but not Stat3 in regenerating liver in mice

European Journal of Clinical Investigation

Volumn 27, Issue 11, 1997, Pages 948-955

  Heim, M H ^a   Gamboni, G ^a   Beglinger, C ^a   Gyr, K ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Liver regeneration; Signal transducers and activators of transcription; Stat; Transcription factors

Indexed keywords

EPIDERMAL GROWTH FACTOR; NUCLEAR FACTOR; SCATTER FACTOR; STAT3 PROTEIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE; FEMALE; LIVER REGENERATION; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

EID: 0030815757     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.2100770.x     Document Type: Article

References (59)

1. Higgins GM, Anderson RM. Restoration of the liver of the white rat following patial surgical removal. Arch Pathol 1931;12:188.
2. Bucher NLR, Malt RA. Regeneration of Liver and Kidney. Boston: Little, Brown & Co., 1971.
3. Bade EG. Biological and ultrastructural aspects of early stages in liver regeneration. In: Teir H, Rytömaa T. Control of Cellular Growth in Adult Organisms. New York. Academic Press, 1967: 260-9.
4. LaBrecque D. Liver regeneration; s picture emerges from the puzzle. Am J Gastroenterol 1994; 89(Suppl. 8):S86-96.
5. Fausto N, Laird AD, Webber EM. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995;9:1527-36.
6. Michalopoulos GK. Control mechanisms of liver regeneration. J Gastroenterol 1994;7:23-9.
7. Taub R. Liver regeneration 4: transcriptional control of liver regeneration. FASEB J 1996;10:413-27.
8. Tomiya T, Tani M, Yamada S, Hayashi S, Umeda N, Fujiwara K. Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients, Gastroenterology 1992;103: 1621-4.
9. Lindroos PM, Zarnegar R, Michaiopoulos GK. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 1991; 13:743-50.
10. Michalopoulos GK. Liver regeneration: molecuiar mechanisms of growth control. FASEB J 1990;4:176-87.
11. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994;12;141-79.
12. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991; 1072:129-57.
13. Haber BA, Mohn KL, Diamond RH, Taub R, Induction patterns of 70 genes during nine days after hepatatomy define the temporal course of liver regeneration. J Clin Investig 1993; 91: 1319-26.
14. Westwick JK, Weitzel C, Leffert HL, Brenner DA. Activation of Jun kinase is an early event in hepatic regeneration. J Clin Invest 1995;95:803-10.
15. Cressman DE, Greenbaum LE, Haber BA, Taub R. Rapid activation of post-hepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver. J Biol Chem 1994; 269:30429-35.
16. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995;376:167-70.
17. Hilberg F, Agguzzi A, Howells N, Wagner EF. c-jun is essential for normal mouse development and hepatogenesis [published erratum appears in Nature 1993;366:368]. Nature 1993;365:179-81.
18. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-21.
19. Ihle JN. Stats- Signal Transducers and Activators of Transcription. Cell 1996;84:31-4.
20. Trautwein C, Rakemann T, Niehof M, Rosejohn S, Manns MP. Acute-phase response factor, increased binding, and target gene transcription during liver regeneration. Gastroenterology 1996;110:1854-62.
21. Wen Z, Zhong Z, Darnell JE Jr. Maximal activation of transcription by Stall and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995;82:241-50.
22. Schindler C, Fu XY, Improta T, Aebersold R, Darnell JE Jr. Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc Natl Acad Sci USA 1992;89:7836-9.
23. Fu XY, Schindler C, Improta T, Aebersold R, Darnell JE Jr. The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction. Proc Natl Acad Sci USA 1992;89:7840-3.
24. Zhong Z, Wen Z, Darnell JE Jr. Stat3 and Stat4: members of the family of signal transducers and activators of transcription. Proc Natl Acad Sci USA 1994;91:4806-10.
25. Ruff-Jamison S, Zhong Z, Wen Z, Chen K, Darnell JE Jr, Cohen S. Epidermal growth factor and lipopolysaccharide activate Stat3 transcription factor in mouse liver. J Biol Chem 1994;269:21933-5.
26. Wagner BJ, Hayes TE, Hoban CJ, Cochran BH. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J 1990;9:4477-84.
27. Schmitt NM, Doppler W, Ball RK, Groner B. Beta-casein gene promoter activity is regulated by the hormone-mediated relief of transcriptional repression and a mammary-gland-specific nuclear factor. Mol Cell Biol 1991;1:3745-55.
28. Ruff-Jamison S, Chen K, Cohen S. Induction by EGF and interferongamma of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. Science 1993;261:1733-6.
29. Ruff-Jamison S, Chen K, Cohen S. Epidermal growth factor induces the tyrosine phosphorylation and nuclear translocation of Stat5 in mouse liver. Proc Natl Acad Sci USA 1995;92:4215-18.
30. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC. Defective Stat Signaling By the Leptin Receptor In Diabetic Mice. Proc Natl Acad Sci USA 1996;93:6231-5.
31. Wakao H, Gouilleux F, Groner B. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J 1994;13: 2182-91.
32. Reich NC, Darnell JE, Jr. Differential binding of interferon-induced factors to an oligonucleotide that mediates transcriptional activation. Nucleic Acids Res 1989;17:3415-24.
33. Qureshi SA, Salditt-Georgieff M, Darnell JE Jr. Tyrosine-phosphorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3. Proc Natl Acad Sci USA 1995;92:3829-33.
34. Seidel HM, Milocco LH, Lamb P, Darnell JE Jr, Stein RB, Rosen J. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci USA 1995;92:3041-5.
35. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-7.
36. Pardee AB. G1 events and regulation of cell proliferation. Science 1989;246:603-8.
37. Hunter T, Pines J. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell 1994;79:573-82.
38. Sherr CJ. Mammalian GI cyclins. Cell 1993;73:1059-65.
39. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994;79:551-5.
40. Elledge SJ, Harper JW. Cdk inhibitors: on the threshold of checkpoints and development. Curr Opin Cell Biol 1994;6:847-52.
41. Akira S, Nishio Y, Inoue M et al. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 1994;77:63-71.
42. Wegenka UM, Lutticken C. Buschmann J et al. The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family. Mol Cell Biol 1994;14:3186-96.
43. Cressman DE, Greenbaum LE, DeAngelis RA et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379-83.
44. Cressman DE, Diamond RH, Taub R. Rapid activation of the Stat3 transcription complex in liver regeneration. Hepatology 1995;21: 1443-9.
45. Mui ALF, Wakao H, Kinoshita T, Kitamura T, Miyajima A. suppression of interleukin-3-induced gene expression by a c-terminal truncated Stat5 - role of Stat5 in proliferation. EMBO J 1996;15:2425-2433.
46. Gobert S, Chretien S, Gouilleux F et al. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for Stat5 activation. EMBO J 1996;5:2434-2441.
47. Chretien S, Varlet P, Verdier F et al. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line tf-1 correlates with impaired stat5 activation. EMBO J 1996;15: 4174-81.
48. Quelle FW, Wang D, Nosaka T et al. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol Cell Biol 1996;16:622-31.
49. Klingmuller U, Bergelson S, Hsiao JG, Lodish HF. Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of Stat5. Proc Natl Acad Sci USA 1996;93:8324-8.
50. Fujii H, Nakagawa Y, Schindler U et al. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. Proc Natl Acad Sci USA 1995;92:5482-6.
51. Shultz LD, Schweitzer PA, Rajan TV et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 1993;73:1445-54.
52. Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995;80:729-38.
53. Chin YE, Kitagawa M, Su WCS, You ZH, Iwamoto Y, Fu XY. Cell growth arrest and induction of cyclin-dependent kinase inhibitor P21 (Waf1/Cip1) mediated by Stat1. Science 1996;272: 719-22.
54. Zhong Z, Wen Z, Darnell JE Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994;264:95-8.
55. Shuai K, Ziemiecki A, Wilks AF et al. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 1993;366:580-3.
56. Sadowski HB, Shuai K, Darnell JE Jr, Gilman MZ. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 1993;261:1739-44.
57. Hibi M, Lin A, Smeal T, Minden A, Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 1993;7:2135-48.
58. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995;270:16483-6.
59. Alcorn JA, Feitelbcrg SP, Brenner DA. Transient induction of c-jun during hepatic regeneration. Hepatology 1990;11:09-15.